Ruth O'Regan
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers (NCT04886531) | Ruth O'Regan | 2022-07-21 |
Track Ruth O'Regan automatically
Every clearance here is in the API, with alerts when new ones post.